We have demonstrated that high levels of CTHRC1 are closely correlated with clinical stage of FIGO classification and prognosis of EOC, suggesting that CTHRC1 serves as a candidate cancer biomarker for the recurrence risk and prognosis in post-operative EOC patients. The gene discussed is CTHRC1; the disease is cancer.